Ban on Hormonal Treatments under Singapore’s New Youth Gender Dysphoria Guidelines

girl staring at herself in the mirror, looking worried

On 5 May 2026, Singapore’s Ministry of Health (MOH) issued a series of new clinical guidelines marking a significant shift in its approach to treating youths with gender dysphoria. The guidelines adopt a cautious stance regarding medical intervention, banning hormonal and surgical treatment for those under the age of 18 and restricting access to such treatment for those aged 18 to 20.

This announcement represents Singapore’s first national framework specifically governing the treatment of gender dysphoria in children and adolescents. This article examines what the new guidelines mean in practice, how they sit with Singapore’s broader legal landscape on transgender rights, the consequences for medical practitioners who do not comply, and the practical options available to affected youths and their families. It covers:

Note: Medical treatment for gender dysphoria may include puberty blockers, hormonal treatment (specifically, gender-affirming hormonal therapy), and gender reassignment surgery. Collectively, these forms of treatment are referred to in this article as gender-affirming medical treatment.

What is Gender Dysphoria?

Gender dysphoria is a recognised clinical condition arising from a mismatch between a person’s gender identity and birth sex. It refers to the distress or impairment in daily functioning that can result from this mismatch. Being transgender and experiencing gender dysphoria are not the same thing – being transgender is merely an aspect of identity describing a person whose gender identity differs from the sex they were assigned at birth, whereas gender dysphoria is the distress arising from not being the sex a person identifies with.

The MOH has established diagnostic criteria for children and adolescents with gender dysphoria, and the Institute of Mental Health (IMH) recognises about 65 patients below the age of 18 with gender dysphoria a year from 2021 to 2025.

What are the New Youth Gender Dysphoria Guidelines?

The new guidelines came in the form of a circular, which all registered medical practitioners in Singapore are obliged to obey. Although the guidelines are not codified in statute, all medical practitioners must comply with them or face professional and regulatory consequences.

​Psychological support as the first line of care

The guidelines firmly establish psychological support as the first line of treatment for youths with gender dysphoria. Psychological support can take the form of therapy and counselling. The reason given for this is that youth are undergoing major physical and psychological changes at this point in their lives and still forming their sense of identity, so they should not make any irreversible decisions about their sex at a young age.

​Ban on hormonal and surgical treatment for those under 18

Children and adolescents below the age of 18 who are diagnosed with gender dysphoria are banned from receiving hormonal and surgical treatment. Even with parental consent, youth under 18 cannot undergo hormonal and surgical treatment for their gender dysphoria.

​Restriction on puberty blockers for those under 21

Puberty blockers, medications used to pause the production of specific sex hormones and bodily changes associated with puberty, will not be allowed for those under the age of 21.

The use of puberty blockers in the context of gender dysphoria has been debated internationally, with ongoing discussions about long-term effects on bone density and fertility. In 2024, the UK banned puberty blockers for those under 18 years of age with gender dysphoria, spurred by research which purportedly showed there was insufficient evidence to show puberty blockers were safe.

Singapore has taken a similarly cautious approach with regard to puberty blockers, and will not allow anyone under the age of 21 to take puberty blockers. The circular notes that there is insufficient evidence on the safety and clinical effectiveness of puberty blockers.

​Limited exceptions for those aged 18 to 20 to receive gender-affirming hormonal therapy

For adolescents aged 18 to 20, limited access to hormonal treatment – specifically, gender-affirming hormonal therapy – may be permitted under exceptional circumstances if the following are fulfilled:

  • There must be clear evidence of benefit of harm reduction (which may include medical/mental health grounds)
  • A Treatment Review Panel, which comprises a multidisciplinary team of relevant specialists, must agree to the treatment
  • There must be informed consent obtained from both the individual and both parents or a legal guardian (if both parents are not available)

The Treatment Review Panel includes the:

  • Attending psychiatrist in charge of the case
  • Attending psychologists, counsellors, and social workers
  • Attending endocrinologist/paediatrician
  • Attending surgeon (if gender reassignment surgery is being considered)
  • One non-treating medical specialist from any of the above groups

There are two types of hormonal therapy. Feminising hormone therapy involves using oestrogen (in the case of a patient who wishes to be feminine-presenting), whereas masculinising hormone therapy uses testosterone (in the case of a patient who wishes to be masculine-presenting) to allow an individual to develop physical features of the affirmed gender. However, note that individuals under 21 cannot receive puberty blockers, which are not the same as hormone therapy. Puberty blockers are medications that stop the progress of puberty, whereas hormone therapy is the introduction of sex hormones into the body.

Once a person turns 21 years old, the person will be considered an adult and can make their own decisions concerning medical procedures.

Does Singapore Recognise Sex Changes in Official Documents?

Individuals who have fully transitioned and undergone gender reassignment surgery can apply to have their sex change reflected on their NRIC. This process requires a physical examination by a relevant medical practitioner confirming that gender-affirming surgery has been completed. Individuals who wish to change their name can apply to do so through a deed poll, but those under the age of 21 may only do so if their parents consent to the process. You may get in touch with our top-rated deed poll lawyers here.

Do Adults Also Need to Undergo Assessment Before Undergoing Gender-Affirming Medical Treatment?

Adults (individuals aged 21 and above) are required to undergo evaluation by a mental health professional or endocrinologist to confirm whether gender-affirming medical treatment, such as hormonal treatment or gender reassignment surgery, is clinically appropriate. As adults have attained the age of majority and can make medical decisions on their own, they are able to independently consent to hormonal therapy or gender reassignment surgery.

For a more detailed discussion, please refer to our article on transgender laws and rights in Singapore, which also covers the framework for gender marker changes, name changes, marriage and National Service considerations.

Can Doctors Face Consequences For Ignoring the New Youth Gender Dysphoria Guidelines?

Yes. The guidelines serve as professional standards that all registered medical practitioners should adopt, and to remind them to continue to comply with their ethical obligations.

If medical practitioners do not meet professional standards required of them, they will be referred to the Singapore Medical Council (SMC) to investigate complaints about a doctor’s conduct and refer them to a Disciplinary Tribunal if necessary. If the doctor has failed to provide professional services to the quality that is reasonably expected of him or her, or has been guilty of professional misconduct,  the Disciplinary Tribunal might fine or suspend the doctor, or even remove them from the medical register.

In addition to the disciplinary consequences, a doctor who prescribes hormonal treatment to or conducts surgery on a minor in contravention of the guidelines might face civil liability if the minor suffers harm as a result.

Even if the guidelines were adhered to and the treatment prescribed was above board, the patient might still suffer a dangerous side effect, such as a failed surgery or severe mood changes. This might result in a claim in medical negligence if informed consent to perform the treatment or surgery was not properly obtained. Given the potentially severe effects of hormonal treatments on a developing body, including effects on bone density, fertility, and growth, it is of utmost importance to ensure that the guidelines are adhered to.

Beyond the SMC, the MOH retains broad supervisory and licensing powers under the Private Hospitals and Medical Clinics Act to allow private hospitals and clinics to operate, and can suspend or revoke these licenses if doctors in such medical facilities flout the guidelines.

For more information, you may wish to refer to our other article on medical negligence and the standard expected of doctors when obtaining informed consent.

What Happens If Parents Disagree With Their Children About Undergoing Gender-Affirming Medical Treatment?

In Singapore, persons below the age of 21 require parental consent for significant medical procedures, including hormonal treatment and gender reassignment surgery. This means that if a parent disagrees and refuses to give consent, a person below the age of 21 generally cannot proceed with hormonal treatment or gender reassignment surgery.

Singapore courts have recognised the concept of Gillick competence (drawn from the UK case of Gillick v West Norfolk and Wisbech Area Health Authority) as part of common law. Gillick competence is the concept that a sufficiently mature and intelligent minor who understands the nature and consequences of a proposed medical procedure may be able to give valid consent without parental authority, even if they are below the age of majority. This is assessed on a case-by-case basis, taking into account the minor’s age, maturity, and comprehension of the risks involved.

However, this common law principle must be read together with the specific requirements of the guidelines by MOH, which explicitly state that youths aged 18 to 20 must obtain parental consent before obtaining hormonal treatment. Any clinician who acts contrary to the guidelines might risk professional regulatory consequences regardless of how mature the patient might seem.

What If You are a Minor Already Receiving Gender-Affirming Medical Treatment?

The guidelines state that such individuals can continue treatment with their existing care teams, but should be reviewed under a Treatment Review Panel to assess potential complications that may arise from treatment. Youths and families in such a position are advised to speak with their treating clinician to discuss the implications of the new guidelines for their ongoing care.

Singapore’s new youth gender dysphoria guidelines represent a significant shift in clinical and regulatory policy within the LGBTQ+ landscape. Singapore has chosen a cautious approach and employed psychological support as the primary treatment pathway, while banning hormonal and surgical treatment for those under the age of 18 and puberty blockers for those under the age of 21. Stringent reviews have also been put in place for those aged 18 to 20 who experience gender dysphoria, who will require agreement from a multidisciplinary Treatment Review Panel to undergo gender-affirming treatment.

For families seeking further guidance, the IMH is Singapore’s specialist mental health institution and can provide referrals to psychiatrists trained in gender dysphoria. If you or someone you know is facing issues with gender dysphoria, it is recommended that you or your loved one obtain psychological help by consulting school counsellors or psychiatric professionals.

Alternatively, you may wish to contact the T Project, a transgender organisation that runs a shelter for homeless transgender people and provides counselling for trans and gender-diverse people. You may also contact Transbefrienders, a registered charity, which provides a befriending programme that matches youths with trained volunteers who have personally experienced gender dysphoria, for peer support.